Dear all,
I'd like to draw your attention to this workshop/seminar set organised by the Swedish national cryo-EM facility together with the national drug discovery and development platform (DDD). Registration is free but you do need to register. https://www.scilifelab.se/event/cryoem-in-drug-discovery/ Best wishes, Annette (DDD crystallography person) ------------------------ CryoEM in Drug Discovery Virtual Event CryoEM has quickly become an essential tool in academic research, with more than 1200 cryoEM structures deposited in the PDB in 2019. CryoEM is now also showing a significant impact on drug discovery in industry and academia. This symposium, co-arranged by the Drug Discovery and Development platform and the CryoEM facility at SciLifeLab, highlights some of the recent advances in the field and familiarises the audience with the requirements, opportunities, and limitations of the technique. Speakers include leading scientists from both major pharma companies and academia. By attending this symposium, you learn what cryoEM can bring to your research, what resources are available to Swedish researchers, and how to get started. We welcome both Swedish and international participants. Session 1 June 8th – Afternoon 14:00 Introduction to the cryo-EM Facility at SciLifelab Marta Carroni, SciLife lab 14:15 From Concept to Reality: CryoEM as an Integral Part of Drug Discovery and Development Corey Strickland; Merck, Kenilworth, United States 15:00 CryoEM at AstraZeneca Chris Phillips; Astra Zeneca, UK 15:30 An integrated cryo-EM and AI based approach for new vaccine identification Ilaria Ferlenghi, GSK, UK 16:00 Cryo-EM structure of Helicobacter pylori urease with an inhibitor in the active site at 1.68 Å resolution Hartmut Luecke, University of Oslo, Norway 16:30 CryoEM in industry, with an artisanal touch Alexi Rohou, Genentech Session 2 June 9th – Morning 09:00 Title TBA Cryo-EM SciLifeLab Facility 09:15 Using Cryo-EM for GPCR Drug Discovery and Development Patrick M. Sexton Monash University, Parkville, Australia 10:00 Cryo-EM at Novartis Maryam Khoshouei, Novartis 10:30 CryoEM of SARM1 reveals a trigger of axon degeneration Katie Cunnea; Evotec, UK 11:00 Concluding Remarks Scientific committee: • Marta Carroni, Head of cryoEM facility; SciLifeLab • Per Arvidsson, Director Drug Discovery and Development platform, SciLifeLab • Anders Olsson, Head of Protein Expression and Characterization facility; SciLifeLab När du har kontakt med oss på Uppsala universitet med e-post så innebär det att vi behandlar dina personuppgifter. För att läsa mer om hur vi gör det kan du läsa här: http://www.uu.se/om-uu/dataskydd-personuppgifter/ E-mailing Uppsala University means that we will process your personal data. For more information on how this is performed, please read here: http://www.uu.se/en/about-uu/data-protection-policy ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/WA-JISC.exe?SUBED1=CCP4BB&A=1 This message was issued to members of www.jiscmail.ac.uk/CCP4BB, a mailing list hosted by www.jiscmail.ac.uk, terms & conditions are available at https://www.jiscmail.ac.uk/policyandsecurity/
